MIO, Catia
 Distribuzione geografica
Continente #
NA - Nord America 2.146
EU - Europa 381
AS - Asia 165
AF - Africa 4
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.700
Nazione #
US - Stati Uniti d'America 2.142
IT - Italia 121
UA - Ucraina 88
CN - Cina 55
DE - Germania 52
IE - Irlanda 38
TR - Turchia 37
VN - Vietnam 31
SE - Svezia 26
IN - India 17
BE - Belgio 15
GB - Regno Unito 15
IR - Iran 12
FI - Finlandia 9
RU - Federazione Russa 9
HK - Hong Kong 6
NL - Olanda 5
TG - Togo 4
BA - Bosnia-Erzegovina 2
CA - Canada 2
CL - Cile 2
KR - Corea 2
MO - Macao, regione amministrativa speciale della Cina 2
MX - Messico 2
AT - Austria 1
BR - Brasile 1
EU - Europa 1
IL - Israele 1
JP - Giappone 1
SG - Singapore 1
Totale 2.700
Città #
Fairfield 295
Chandler 227
Woodbridge 198
Seattle 154
Ashburn 148
Wilmington 137
Houston 118
Cambridge 111
Ann Arbor 98
New York 49
Udine 48
Jacksonville 47
Dearborn 46
Redmond 43
Dublin 38
Izmir 37
Dong Ket 31
Princeton 29
Beijing 27
Ogden 20
Codroipo 18
Boardman 17
Brussels 15
Des Moines 11
Norwalk 10
San Diego 8
San Mateo 8
Augusta 7
Pune 7
Falls Church 6
Grafing 6
Leawood 5
Ardabil 4
Cagliari 4
Hefei 4
Hong Kong 4
Lomé 4
London 4
Nanchang 4
Nanjing 4
Trento 4
Chengdu 3
Dallas 3
Los Angeles 3
Monmouth Junction 3
Portici 3
Reggio Nell'emilia 3
Bari 2
Bijeljina 2
Castelfranco Veneto 2
Chions 2
Cuernavaca 2
Gangnam-gu 2
Jinan 2
Kashan 2
Macao 2
Mumbai 2
Naples 2
New Delhi 2
Phoenix 2
Tappahannock 2
Tavagnacco 2
Toronto 2
Torre Del Greco 2
Xi'an 2
Andover 1
Cachoeira do Sul 1
Cadoneghe 1
Changsha 1
Edinburgh 1
Fisciano 1
Hangzhou 1
Harbin 1
Kunming 1
Lappeenranta 1
Monfalcone 1
Montebelluna 1
Napoli 1
Parma 1
Premariacco 1
Rome 1
Sacramento 1
Serio 1
Tel Aviv 1
Tokyo 1
Trieste 1
Venezia 1
Washington 1
Wuhan 1
Zanjan 1
Zhengzhou 1
Totale 2.135
Nome #
Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells 149
null 146
BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells 128
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells 127
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells 126
Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer 125
null 118
Inhibition of APE1-endonuclease activity affects cell metabolism in colon cancer cells via a p53-dependent pathway 117
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells 112
Nanoparticles loaded with the BET inhibitor JQ1 block the growth of triple negative breast cancer cells in vitro and in vivo 109
Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line 105
null 102
null 98
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches 98
A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma 89
Analysis of the biological mechanisms de-regulated after pharmacological BET inhibition in a model of anaplastic thyroid cancer 87
null 84
CACNA1C haploinsufficiency accounts for the common features of interstitial 12p13.33 deletion carriers 75
null 63
Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma 62
Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN 61
BAZ1B is a candidate gene responsible for hypothyroidism in Williams syndrome 59
Molecular defects in thyroid dysgenesis 57
Correction to: Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma (Endocrine, (2020), 10.1007/s12020-020-02221-8) 37
Missense NR2F1 variant in monozygotic twins affected with the Bosch–Boonstra–Schaaf optic atrophy syndrome 37
A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow Validation 37
Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli Venezia Giulia 35
Challenges in promoter methylation analysis in the new era of translational oncology: a focus on liquid biopsy 34
A paternally inherited 1.4 kb deletion of the 11p15.5 imprinting center 2 is associated with a mild familial Silver–Russell syndrome phenotype 32
Effects of nutraceuticals on anaplastic thyroid cancer cells 31
Biological and molecular effects of bromodomain and extra-terminal (BET) inhibitors JQ1, IBET-151, and IBET-762 in OSCC cells 28
Validation of a One-Step Reverse Transcription-Droplet Digital PCR (RT-ddPCR) Approach to Detect and Quantify SARS-CoV-2 RNA in Nasopharyngeal Swabs 28
Rare germline variants in DNA repair-related genes are accountable for papillary thyroid cancer susceptibility 24
A novel de novo HDAC8 missense mutation causing Cornelia de Lange syndrome 23
BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy 21
MCM5 as a target of BET inhibitors in thyroid cancer cells 20
Expression of PAX8 target genes in papillary thyroid carcinoma 20
Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells 19
A novel de novo NIPA1 missense mutation associated to hereditary spastic paraplegia 19
Monitoring the SPREAD of the SARS-CoV-2 lineage B.1.621 in Udine, Italy 17
Role of m6A RNA Methylation in Thyroid Cancer Cell Lines 15
Pro‐inflammatory microenvironment modulates the transfer of mutated tp53 mediated by tumor exosomes 12
Somatic genomic imbalances in ‘tumour-free’ surgical margins of oral cancer 11
NK2 homeobox gene cluster: Functions and roles in human diseases 9
Monoallelic variants resulting in substitutions of MAB21L1 Arg51 Cause Aniridia and microphthalmia 8
Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients’ Plasma 7
RNA Profile of Cell Bodies and Exosomes Released by Tumorigenic and Non-Tumorigenic Thyroid Cells 6
Filamin C (FLNC) truncating mutation in a fatal arrhythmogenic left ventricular cardiomyopathy (ALVC) 6
Reading cancer: Chromatin readers as druggable targets for cancer treatment 6
Novel IGFALS mutations with predicted pathogenetic effects by the analysis of AlphaFold structure 6
Effects of HuR downregulation on anaplastic thyroid cancer cells 5
A bird’s eye view on the use of whole exome sequencing in rare congenital ophthalmic diseases 3
Totale 2.853
Categoria #
all - tutte 10.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.469


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201957 0 0 0 0 0 0 0 0 0 0 0 57
2019/2020796 31 19 58 107 62 92 128 94 89 54 26 36
2020/2021510 24 40 32 44 26 63 29 49 47 29 70 57
2021/2022397 32 40 8 14 14 14 21 27 10 41 137 39
2022/2023439 34 53 5 65 50 113 3 34 51 6 12 13
2023/2024306 19 14 5 6 49 75 9 23 41 30 17 18
Totale 2.853